Everything you need to know about the Johnson & Johnson scare
POLITICO Tech
English - April 14, 2021 09:30 - 16 minutes - 15.1 MB - ★★★★ - 364 ratingsDaily News News Politics briefings capitol hill daily news political politico news politics white house policy congress Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
POLITICO’s Sarah Owermohle is one of more than 6 million people who got
the Johnson & Johnson coronavirus vaccine before regulators pressed the
pause button over fears of extremely rare blood clotting events.
Owermohle joins Dispatch to break down regulators’ decision to halt the
J&J shots — and what it could mean for vaccine hesitancy. Plus, new data
shows that 80 percent of student loan borrowers would have their debt
completely erased if Biden agrees to a progressive proposal. And HUD
moves to restore fair housing rules weakened under Trump.
Sarah Owermohle is a health care reporter for POLITICO.
Jeremy Siegel is a host for POLITICO Dispatch.
Jenny Ament is the senior producer of POLITICO audio.
Irene Noguchi is the executive producer of POLITICO audio.
Read more: Biden officials bracing for possibility of weekslong
disruption to J&J vaccine supply
POLITICO’s Sarah Owermohle is one of more than 6 million people who got the Johnson & Johnson coronavirus vaccine before regulators pressed the pause button over fears of extremely rare blood clotting events. Owermohle joins Dispatch to break down regulators’ decision to halt the J&J shots — and what it could mean for vaccine hesitancy. Plus, new data shows that 80 percent of student loan borrowers would have their debt completely erased if Biden agrees to a progressive proposal. And HUD moves to restore fair housing rules weakened under Trump.
Sarah Owermohle is a health care reporter for POLITICO.
Jeremy Siegel is a host for POLITICO Dispatch.
Jenny Ament is the senior producer of POLITICO audio.
Irene Noguchi is the executive producer of POLITICO audio.
Read more: Biden officials bracing for possibility of weekslong disruption to J&J vaccine supply